US$ 28.74
kiaora glp 1 FDA approves Foundayo, an oral GLP-1 alternative to Wegovy and Ozempic Are GLP-1 drugs worth their
Description
doi: 10.1002/oby.22430

Strong healthcare infrastructure, established reimbursement systems, and widespread physician adoption further support market penetration
Some Ozempic side effects and reactions may be life-threatening

However, there were only 444 patients with the administration of GLP-1 RAs
